Pharmaceutical Market Europe • June 2025 • 5

CONTENTS

June 2025

NEWS & COLUMNS


6-7 NEWS
BMS and BioNTech agree on $11bn oncology deal; Eli Lilly’s Omvoh recommended by NICE

8-9 NEWS
Roche's 96-week results for MS candidate; BioNTech commits £1bn to boost UK presence

10-11 DERMATOLOGY NEWS
J&J/Protagonist’s icotrokinra shows promise in psoriasis; FDA approves Arcutis’ Zoryve foam

12 DARWIN'S MEDICINE
Traitorous doubts about strategic decisions

13 CAMERAS ON...
Some of the arguments for and against having cameras on in a virtual meeting

14 INNOVATIVE IMPACT
Leveraging AI to supercharge early
commercialisation strategy

15 THE BUSINESS CASE FOR DEI
Progress takes commitment, courage and action

FEATURES


16-17 ALZHEIMER’S DISEASE – THE SILENT PANDEMIC AND THE POSITIVE IMPACT OF AI
Dementia affects over 55 million people
worldwide, but there is hope that, using AI, future eye exams could be used to detect early signs of Alzheimer’s and heart disease

20-22 SEPSIS AND THE IMPACT OF ANTIBIOTIC RESISTANCE
A WHO report emphasises the serious global impact of antimicrobial resistance, which exacerbates the substantial burden of sepsis on patients, HCPs and health systems

24-26 ASCO 2025 – BRINGING A SENSE OF URGENCY TO THE WAR AGAINST CANCER
‘Hot’ tumours, breast cancer breakthroughs and holistic treatment were the standouts at this year’s event, with ASCO 2025 making it clear that the future of cancer care won’t be determined by science alone

COMMUNIQUE
MARKETING & COMMS


28-30 COMMUNICATING WITH HCPS THROUGH AI TAKES FINESSE, FLEXIBILITY AND THE HUMAN TOUCH
While AI’s influence is growing across drug discovery, clinical trials and supply chains, it doesn’t provide that peer-to-peer discussion and sharing of opinions that HCPs want and need

34-35 A NEW ERA OF DOMESTIC PHARMA MANUFACTURING
With tariffs threatening the sector’s low-cost sourcing playbook, pharma is being forced to rethink supply chain resilience from the ground up

36-37 REDEFINING THE BIOTECH LANDSCAPE
Short-term uncertainty is slowing investment activity, but the long-term outlook remains strong

39 HEALTHCARE COMMS
Envision Pharma Group unveils new agency structure

CAREERS & RECRUITMENT


40-42 APPOINTMENTS
Each month, we bring you the latest news on job changes in the pharma sector. This month, we are highlighting changes at Ochre Bio, Bristol Myers Squibb and MC2